Cambrex Corp. Company Profile (NYSE:CBM)

About Cambrex Corp.

Cambrex Corp. logoCambrex Corporation (Cambrex) is a life sciences company. The Company provides products and services for the development and commercialization of new and generic therapeutics. The Company supplies its products and services across the world to generic pharmaceutical companies. Cambrex operates through three segments, which are manufacturing facilities. The Company's manufacturing facilities are located in the Europe and the United States. The Company's business consists of the custom development and manufacture of pharmaceutical ingredients derived from organic chemistry. The Company's products include active pharmaceutical ingredients (APIs), pharmaceutical intermediates and other fine chemicals. The Company's products and services are sold around the world under trademarks that are owned by the Company. This includes Profarmaco, which is registered around the world as a word and design mark. Its products are sold through a combination of direct sales and independent agents.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: Life Sciences Tools & Services
  • Exchange: NYSE
  • Symbol: CBM
  • CUSIP: 13201110
Key Metrics:
  • Previous Close: $45.52
  • 50 Day Moving Average: $45.28
  • 200 Day Moving Average: $47.69
  • 52-Week Range: $29.50 - $59.41
  • Trailing P/E Ratio: 22.99
  • Foreward P/E Ratio: 15.65
  • P/E Growth: 1.20
  • Market Cap: $1.46B
  • Outstanding Shares: 32,147,000
  • Beta: 1.45
Profitability:
  • Net Margins: 13.97%
  • Return on Equity: 24.86%
  • Return on Assets: 15.24%
Debt:
  • Current Ratio: 3.47%
  • Quick Ratio: 1.73%
Additional Links:
Companies Related to Cambrex Corp.:

Analyst Ratings

Consensus Ratings for Cambrex Corp. (NYSE:CBM) (?)
Ratings Breakdown: 2 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $60.00 (31.75% upside)

Analysts' Ratings History for Cambrex Corp. (NYSE:CBM)
Show:
DateFirmActionRatingPrice TargetDetails
2/11/2016Singular ResearchLower Price TargetBuy$63.00 -> $60.00View Rating Details
2/1/2016SidotiInitiated CoverageBuy$60.00View Rating Details
7/31/2015Longbow ResearchReiterated RatingBuy$48.00 -> $60.00View Rating Details
7/21/2015StephensInitiated CoverageOverweight$55.00View Rating Details
3/31/2015Craig HallumInitiated CoverageBuy$50.00View Rating Details
(Data available from 9/28/2014 forward)

Earnings

Earnings History for Cambrex Corp. (NYSE:CBM)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/1/2016        
7/28/2016Q216$0.59$0.68$114.85 million$118.22 millionViewListenView Earnings Details
4/29/2016Q116$0.34$0.50$83.61 million$94.74 millionViewListenView Earnings Details
2/9/2016Q4$0.83$0.54$152.94 million$156.90 millionViewListenView Earnings Details
11/3/2015Q3$0.38$0.40$101.09 million$92.97 millionViewListenView Earnings Details
7/30/2015Q215$0.44$0.63$110.03 million$106.40 millionViewListenView Earnings Details
5/1/2015Q115$0.23$0.29$76.01 million$78.20 millionViewListenView Earnings Details
2/6/2015Q414$0.50$0.64$117.90 million$128.80 millionViewListenView Earnings Details
10/30/2014Q314$0.26$0.28$94.25 million$81.10 millionViewListenView Earnings Details
8/12/2014$0.21$0.32ViewN/AView Earnings Details
8/1/2014Q214$0.28$0.35$92.70 million$98.00 millionViewListenView Earnings Details
5/2/2014Q114$0.23$0.07$79.40 million$66.20 millionViewListenView Earnings Details
2/11/2014Q4$0.30$0.30$95.25 million$103.00 millionViewListenView Earnings Details
11/1/2013Q313$0.21$0.20$83.60 million$78.00 millionViewListenView Earnings Details
8/1/2013Q2 2013$0.26$0.10$73.70 million$61.60 millionViewListenView Earnings Details
5/3/2013Q1 2013$0.22$0.36$76.15 million$74.58 millionViewListenView Earnings Details
2/6/2013Q4 2012$0.13$0.26$68.30 million$69.93 millionViewListenView Earnings Details
11/5/2012Q312$0.12$0.07$61.00 million$59.21 millionViewN/AView Earnings Details
8/1/2012$0.21$0.33ViewN/AView Earnings Details
5/3/2012$0.14$0.24ViewN/AView Earnings Details
2/6/2012$0.12$0.10ViewN/AView Earnings Details
11/3/2011$0.07$0.10ViewN/AView Earnings Details
8/2/2011$0.13$0.16ViewN/AView Earnings Details
5/5/2011$0.08$0.10ViewN/AView Earnings Details
2/10/2011$0.10$0.16ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Cambrex Corp. (NYSE:CBM)
Current Year EPS Consensus Estimate: $2.56 EPS
Next Year EPS Consensus Estimate: $2.91 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161$0.25$0.25$0.25
Q2 20161$0.48$0.48$0.48
Q3 20162$0.40$0.45$0.43
Q4 20162$0.93$0.97$0.95
Q1 20171$0.52$0.52$0.52
Q2 20171$0.70$0.70$0.70
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Cambrex Corp. (NYSE:CBM)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Cambrex Corp. (NYSE:CBM)
Insider Ownership Percentage: 2.63%
Institutional Ownership Percentage: 99.46%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/11/2016William B KorbDirectorSell3,420$55.00$188,100.00View SEC Filing  
6/8/2016William B KorbDirectorSell4,142$52.47$217,330.74View SEC Filing  
6/1/2016William B KorbDirectorSell8,000$51.06$408,480.00View SEC Filing  
5/9/2016Steven M KloskCEOSell14,005$49.00$686,245.00View SEC Filing  
5/5/2016Steven M KloskCEOSell16,430$49.13$807,205.90View SEC Filing  
5/3/2016William B KorbDirectorSell8,000$49.09$392,720.00View SEC Filing  
3/16/2016Steven M KloskCEOSell19,565$41.00$802,165.00View SEC Filing  
3/15/2016Louis J GrabowskyDirectorBuy750$40.10$30,075.00View SEC Filing  
3/10/2016William B KorbDirectorSell8,000$41.38$331,040.00View SEC Filing  
2/11/2016Gregory SargenCFOSell13,622$36.16$492,571.52View SEC Filing  
2/11/2016Shawn CavanaghCOOSell18,342$36.13$662,696.46View SEC Filing  
2/11/2016Steven M. KloskCEOSell39,542$36.20$1,431,420.40View SEC Filing  
12/15/2015Leon J. Hendrix, Jr.DirectorSell7,000$51.34$359,380.00View SEC Filing  
12/11/2015Peter G. TombrosDirectorSell31,236$51.37$1,604,593.32View SEC Filing  
11/30/2015Ilan KaufthalDirectorSell52,315$54.32$2,841,750.80View SEC Filing  
11/13/2015Gregory SargenCFOSell28,750$49.14$1,412,775.00View SEC Filing  
11/6/2015Samantha HanleyVPSell15,000$52.03$780,450.00View SEC Filing  
8/27/2015William B. KorbDirectorSell3,600$48.00$172,800.00View SEC Filing  
5/21/2015Ilan KaufthalDirectorSell50,000$41.31$2,065,500.00View SEC Filing  
5/11/2015Gregory SargenCFOSell25,000$38.44$961,000.00View SEC Filing  
2/12/2015Aldo MagniniDirectorSell7,500$32.75$245,625.00View SEC Filing  
2/12/2015Gregory SargenCFOSell25,000$32.64$816,000.00View SEC Filing  
2/10/2015Steven M KloskCEOSell45,000$30.32$1,364,400.00View SEC Filing  
9/11/2014Shawn CavanaghCOOSell56,251$22.56$1,269,022.56View SEC Filing  
9/3/2014Steven M KloskCEOSell126,257$22.01$2,778,916.57View SEC Filing  
9/2/2014William M HaskelSVPSell9,400$21.94$206,236.00View SEC Filing  
8/19/2014Steven M KloskCEOSell4,702$22.00$103,444.00View SEC Filing  
8/7/2014Steven M KloskCEOSell1,200$22.52$27,024.00View SEC Filing  
8/7/2014William M HaskelSVPSell28,100$22.50$632,250.00View SEC Filing  
8/5/2014Gregory SargenCFOSell50,000$22.34$1,117,000.00View SEC Filing  
2/28/2014Leon Hendrix, Jr.DirectorSell23,000$20.09$462,070.00View SEC Filing  
2/20/2014Aldo MagniniDirectorSell6,000$22.10$132,600.00View SEC Filing  
12/5/2013Paolo RussoloInsiderSell35,000$18.40$644,000.00View SEC Filing  
11/11/2013Gregory SargenCFOSell20,000$18.92$378,400.00View SEC Filing  
11/11/2013John MillerDirectorSell2,000$19.21$38,420.00View SEC Filing  
5/24/2013Paolo RussoloInsiderSell32,903$12.53$412,274.59View SEC Filing  
5/16/2013Leon J Hendrix JrDirectorSell1,120$13.40$15,008.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Cambrex Corp. (NYSE:CBM)
DateHeadline
4-traders.com logoCambrex : E. RUTHERFORD'S CAMBREX IN $25M DEAL (NYSE:CBM)
www.4-traders.com - September 27 at 4:02 PM
finance.yahoo.com logoNovartis Ilaris Approved for Extended Use in Periodic Fever - Yahoo Finance (NYSE:CBM)
finance.yahoo.com - September 26 at 4:19 PM
finance.yahoo.com logoNovartis Ilaris Approved for Extended Use in Periodic Fever - Yahoo Finance (NYSE:CBM)
finance.yahoo.com - September 26 at 4:19 PM
streetinsider.com logoCambrex Corp. (CBM) to Acquire Privately-Held PharmaCore for ~$25M - StreetInsider.com (NYSE:CBM)
www.streetinsider.com - September 26 at 8:52 AM
publicnow.com logoCambrex to Acquire PharmaCore Inc., to Expand Clinical Stage API Capabilities (NYSE:CBM)
www.publicnow.com - September 26 at 8:52 AM
4-traders.com logoCambrex : Announces Investment and Expansion to Large Scale, Multi-Purpose Manufacturing Capabilities at its Karlskoga, Sweden, Facility (NYSE:CBM)
www.4-traders.com - September 25 at 3:47 PM
zacks.com logoThe Medicines Co. to Get BARDA Funding for Infection Drugs (NYSE:CBM)
www.zacks.com - September 22 at 9:45 AM
stocksdaily.net logoCambrex Corporation (NYSE:CBM) Had $43.974 In Cash And Short-Term Investments (NYSE:CBM)
www.stocksdaily.net - September 22 at 9:45 AM
stocksdaily.net logoCambrex Corporation (NYSE:CBM) Had $43.974 In Cash And Short-Term Investments - Stocks Daily (NYSE:CBM)
www.stocksdaily.net - September 21 at 4:46 PM
fool.com logoRetired? 3 Stocks You Should Consider Buying (NYSE:CBM)
www.fool.com - September 21 at 4:46 PM
News IconShares Have Ticked Up Over the Last Five Trading Sessions: Cambrex Corporation (NYSE:CBM) - Post News (NYSE:CBM)
www.kentuckypostnews.com - September 20 at 9:57 AM
zacks.com logoNovo Nordisk (NVO) Presents Data on Obesity Drug Saxenda (NYSE:CBM)
www.zacks.com - September 15 at 12:19 PM
News IconStock Up Over the Past Five Trading Sessions: Cambrex Corporation (NYSE:CBM) - Post News (NYSE:CBM)
www.kentuckypostnews.com - September 13 at 8:56 AM
kcregister.com logoBest Stocks: Cambrex Corporation (NYSE:CBM), Cameco Corporation (NYSE:CCJ), Enduro Royalty Trust (NYSE ... - KC Register (NYSE:CBM)
www.kcregister.com - September 12 at 8:54 AM
News IconShares Lower Over the Past Quarter: Cambrex Corporation (NYSE:CBM) - Post News (NYSE:CBM)
www.kentuckypostnews.com - September 11 at 8:44 AM
publicnow.com logoAdvantages of Integrating Biocatalytic Transformations into Small Molecule Synthesis to be Presented by Cambrex Expert (NYSE:CBM)
www.publicnow.com - September 8 at 3:59 PM
News IconStock Sliding Down Over the Last Month: Cambrex Corporation (NYSE:CBM) - Post News (NYSE:CBM)
www.kentuckypostnews.com - September 8 at 6:24 AM
zacks.com logoWhat Makes XBiotech (XBIT) a Strong Sell? (NYSE:CBM)
www.zacks.com - September 7 at 9:45 AM
finance.yahoo.com logo10:02 am Cambrex announces $9 mln investment to expand large scale manufacturing capacity at its Karlskoga facility in Sweden (NYSE:CBM)
finance.yahoo.com - September 6 at 3:58 PM
publicnow.com logoCambrex Announces Investment and Expansion to Large Scale, Multi-Purpose Manufacturing Capabilities at its Karlskoga, Sweden, Facility (NYSE:CBM)
www.publicnow.com - September 6 at 3:58 PM
feeds.reuters.com logoBRIEF-Cambrex says SEK 72 mln investment to expand manufacturing capacity at Karlskoga facility in Sweden (NYSE:CBM)
feeds.reuters.com - September 6 at 11:00 AM
stocksdaily.net logoCambrex Corporation (NYSE:CBM) Held $43.974 In Cash And Short-Term Investments - Stocks Daily (NYSE:CBM)
www.stocksdaily.net - September 2 at 3:54 PM
stocksdaily.net logoCambrex Corporation (NYSE:CBM) Held $43.974 In Cash And Short-Term Investments (NYSE:CBM)
www.stocksdaily.net - August 31 at 4:01 PM
finance.yahoo.com logoCan Cambrex (CBM) Keep the Earnings Streak Alive This Quarter? (NYSE:CBM)
finance.yahoo.com - August 31 at 4:01 PM
finance.yahoo.com logoCambrex (CBM) is Oversold: Can It Recover? (NYSE:CBM)
finance.yahoo.com - August 30 at 11:57 AM
publicnow.com logoCambrex to Present at Upcoming Investor Conferences in September (NYSE:CBM)
www.publicnow.com - August 26 at 12:10 PM
capitalcube.com logoETF’s with exposure to Cambrex Corp. : August 22, 2016 (NYSE:CBM)
www.capitalcube.com - August 22 at 4:09 PM
zacks.com logoSanofi Diabetes Combination Drug FDA Action Date Extended (NYSE:CBM)
www.zacks.com - August 22 at 8:52 AM
finance.yahoo.com logoIs Cambrex Corporation (CBM) a Great Growth Stock? (NYSE:CBM)
finance.yahoo.com - August 4 at 12:44 PM
equities.com logoCambrex Corporation (CBM) is Trading Lower on Unusual Volume for August 01 - Equities.com (NYSE:CBM)
www.equities.com - August 3 at 4:09 PM
finance.yahoo.com logoCAMBREX CORP Financials (NYSE:CBM)
finance.yahoo.com - August 3 at 4:09 PM
capitalcube.com logoCambrex Corp. :CBM-US: Earnings Analysis: Q2, 2016 By the Numbers : August 3, 2016 (NYSE:CBM)
www.capitalcube.com - August 3 at 4:09 PM
fool.com logoThis Under-the-Radar Stock Powers the Pharma Industry -- and It Just Raised 2016 Guidance (NYSE:CBM)
www.fool.com - August 2 at 6:22 PM
seekingalpha.com logoBiotech Forum Daily Digest: The Rally Continues, Finally Some Good News For Ionis, Spotlight On Cambrex (NYSE:CBM)
seekingalpha.com - August 1 at 4:03 PM
seekingalpha.com logoBiotech Forum Daily Digest: The Rally Continues, Finally Some Good News For Ionis, Spotlight On Cambrex (NYSE:CBM)
seekingalpha.com - August 1 at 4:03 PM
equities.com logoCambrex Corporation (CBM) is Trading Higher on Unusual Volume for July 27 - Equities.com (NYSE:CBM)
www.equities.com - July 29 at 9:33 PM
4-traders.com logoCambrex : posts 2Q profit (NYSE:CBM)
www.4-traders.com - July 29 at 4:07 PM
equities.com logoCambrex Corporation (CBM) is Trading Lower on Unusual Volume for July 26 - Equities.com (NYSE:CBM)
www.equities.com - July 29 at 5:35 AM
streetinsider.com logoCambrex Corp. (CBM) Gains as Q2 Tops Views, Guidance Raised - StreetInsider.com (NYSE:CBM)
www.streetinsider.com - July 29 at 5:35 AM
rttnews.com logoCambrex Corp. Reveals 9% Increase In Q2 Earnings (NYSE:CBM)
www.rttnews.com - July 28 at 10:45 PM
rttnews.com logoCambrex Lifts FY16 Forecast As Q2 Results Top Estimates - Quick Facts (NYSE:CBM)
www.rttnews.com - July 28 at 12:50 PM
sg.finance.yahoo.com logoCambrex posts 2Q profit (NYSE:CBM)
sg.finance.yahoo.com - July 28 at 11:40 AM
equities.com logoCambrex Corporation (CBM) Drops 11.56% on July 26 - Equities.com (NYSE:CBM)
www.equities.com - July 27 at 9:49 PM
fortune.com logoCambrex Corporation (NYSE:CBM) Insider Activities Are in the Air - Review Fortune (NYSE:CBM)
reviewfortune.com - July 27 at 12:40 PM
capitalcube.com logoCambrex Corp. breached its 50 day moving average in a Bearish Manner : CBM-US : July 27, 2016 (NYSE:CBM)
www.capitalcube.com - July 27 at 8:22 AM
investors.com logoStocks Try To Close Higher, But Bears Swat Centene, Mobileye (NYSE:CBM)
www.investors.com - July 26 at 3:45 PM
publicnow.com logoCambrex to Announce Second Quarter 2016 Financial Results on July 28, 2016 (NYSE:CBM)
www.publicnow.com - July 26 at 1:28 PM
equities.com logoCambrex Corporation (CBM) Hits New 52-week High During July 21 Session - Equities.com (NYSE:CBM)
www.equities.com - July 23 at 8:23 AM
News IconWhat's Propelling Cambrex Corporation to Reach All-Time High? - Consumer Eagle (NYSE:CBM)
www.consumereagle.com - July 21 at 8:02 AM
stocksdaily.net logoCash And Short-Term Investments For Cambrex Corporation (NYSE:CBM) Was $43.974 - Stocks Daily (NYSE:CBM)
www.stocksdaily.net - July 20 at 5:10 PM

Social

Cambrex Corp. (NYSE:CBM) Chart for Wednesday, September, 28, 2016


Last Updated on 9/28/2016 by MarketBeat.com Staff